- Home
- ZEUS vs ZBIO Comparison
ZEUS vs ZBIO Comparison
Compare ZEUS & ZBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZEUS
- ZBIO
- Stock Information
- Founded
- ZEUS 1954
- ZBIO 2019
- Country
- ZEUS United States
- ZBIO United States
- Employees
- ZEUS N/A
- ZBIO N/A
- Industry
- ZEUS Metal Fabrications
- ZBIO
- Sector
- ZEUS Industrials
- ZBIO
- Exchange
- ZEUS Nasdaq
- ZBIO NYSE
- Market Cap
- ZEUS 371.7M
- ZBIO 339.3M
- IPO Year
- ZEUS 1994
- ZBIO 2024
- Fundamental
- Price
- ZEUS $33.72
- ZBIO $7.85
- Analyst Decision
- ZEUS
- ZBIO Strong Buy
- Analyst Count
- ZEUS 0
- ZBIO 5
- Target Price
- ZEUS N/A
- ZBIO $31.75
- AVG Volume (30 Days)
- ZEUS 84.1K
- ZBIO 390.2K
- Earning Date
- ZEUS 02-20-2025
- ZBIO 02-16-2025
- Dividend Yield
- ZEUS 1.78%
- ZBIO N/A
- EPS Growth
- ZEUS N/A
- ZBIO N/A
- EPS
- ZEUS 2.27
- ZBIO N/A
- Revenue
- ZEUS $2,012,296,000.00
- ZBIO N/A
- Revenue This Year
- ZEUS N/A
- ZBIO N/A
- Revenue Next Year
- ZEUS $5.62
- ZBIO N/A
- P/E Ratio
- ZEUS $14.83
- ZBIO N/A
- Revenue Growth
- ZEUS N/A
- ZBIO N/A
- 52 Week Low
- ZEUS $30.29
- ZBIO $7.50
- 52 Week High
- ZEUS $73.49
- ZBIO $26.25
- Technical
- Relative Strength Index (RSI)
- ZEUS 44.52
- ZBIO N/A
- Support Level
- ZEUS $30.29
- ZBIO N/A
- Resistance Level
- ZEUS $33.85
- ZBIO N/A
- Average True Range (ATR)
- ZEUS 1.18
- ZBIO 0.00
- MACD
- ZEUS 0.41
- ZBIO 0.00
- Stochastic Oscillator
- ZEUS 91.47
- ZBIO 0.00
About ZEUS Olympic Steel Inc.
Olympic Steel Inc provides metals processing and distribution services in the United States. The company operates in three reportable segments; specialty metals flat products, carbon flat products, and tubular and pipe products. It specializes in the processing and distribution of large volumes of carbon, aluminum, and stainless steel flat-rolled sheet, coils, plates, bars, and fabricated parts. The group serves various industries such as industrial machinery and equipment manufacturers, automobile manufacturers and suppliers, and transportation equipment manufacturers. The company generates majority of the revenue from carbon flat products.
About ZBIO ZENAS BIOPHARMA INC
Zenas BioPharma Inc is a clinical-stage biopharmaceutical company. Its I&I product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are present across B cell lineage, in order to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them.